Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37. Effects on the production of inflammatory mediators by mouse macrophages

International Journal of Experimental Pathology

Volumn 92, Issue 6, 2011, Pages 382-391

  Ciszek Lenda, Marta ^b   Nowak, Bernadeta ^b   Śróttek, Malgorzata ^b   Gamian, Andrzej ^b   Marcinkiewicz, Janusz ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cytokines; Exopolysaccharides; Lactobacillus rhamnosus; Macrophages; Probiotics

Indexed keywords

EXOPOLYSACCHARIDE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL CELL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; IMMUNOREGULATION; IMMUNOSTIMULATION; LACTOBACILLUS RHAMNOSUS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LACTOBACILLUS RHAMNOSUS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED CBA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, ANIMAL; POLYSACCHARIDES, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82355191743     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00788.x     Document Type: Article

References (41)

1. Christensen H.R., Frøkiaer H., Pestka J.J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168, 171-178.
2. Ciszek-Lenda M. (2011) Biological functions of exopolysaccharides from probiotic bacteria. Centr. Eur. J. Immunol. 36, 51-55.
3. Dalpke A.H., Frey M., Morath S., Hartung T., Heeg K. (2002) Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells. Immunobiology 206, 392-407.
4. Ding A.H., Nathan C.F., Stuehr D.J. (1988) Release of reactive nitrogen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
5. Dong C., Davis R.J., Flavell R.A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72.
6. Dowling D., Hamilton C.M., O'Neill S.M. (2008) A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 41, 254-262.
7. Erroi A., Fantuzzi G., Mengozzi M. et al. (1993) Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect. Immun. 61, 4356-4359.
8. Ferrie S. & Daley M. (2011) Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: randomized controlled trial. J. Parenter. Enteral. Nutr. 35, 43-49.
9. Flemming H.C., Neu T.R., Wozniak D.J. (2007) The EPS matrix: the "house of biofilm cells". J. Bacteriol. 189, 7945-7947.
10. Hojsak I., Abdović S., Szajewska H., Milosević M., Krznarić Z., Kolacek S. (2010) Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125, 1171-1177.
11. Kaji R., Kiyoshima-Shibata J., Nagaoka M., Nanno M., Shida K. (2010) Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J. Immunol. 184, 3505-3513.
12. Kim H.G., Gim M.G., Kim J.Y. et al. (2007) Lipoteichoic acid from Lactobacillus plantarum elicits both the production of interleukin-23p19 and suppression of pathogen-mediated interleukin-10 in THP-1 cells. FEMS Immunol Med Microbio 49, 205-214.
13. Laws A., Gu Y., Marshall V. (2001) Biosynthesis, characterization, and design of bacterial exopolysaccharides from lactic acid bacteria. Biotechnol. Adv. 19, 597-625.
14. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., Hartung T. (2001) Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166, 5161-5167.
15. Lipiński T., Jones C., Lemercinier X. et al. (2003) Structural analysis of the Lactobacillus rhamnosus strain KL37C exopolysaccharide. Carbohydr. Res. 338, 605-609.
16. Marcinkiewicz J., Ciszek M., Bobek M. et al. (2007) Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol. 88, 155-164.
17. Marcone V., Calzolari E., Bertini M. (2008) Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol. 31, 429-433.
18. Martin M., Katz J., Vogel S.N., Michalek S.M. (2001) Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol. 167, 5278-5285.
19. Matsuguchi T., Takagi A., Matsuzaki T. et al. (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immunol. 10, 259-266.
20. Matsumoto S., Hara T., Hori T. et al. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140, 417-426.
21. Mohamadzadeh M., Olson S., Kalina W.V. et al. (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA 8, 2880-2885.
22. Nermes M., Kantele J.M., Atosuo T.J., Salminen S., Isolauri E. (2011) Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin. Exp. Allergy 41, 370-377.
23. Prescott S.L., Wickens K., Westcott L. et al. (2008) Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin. Exp. Allergy 38, 1606-1614.
24. Rachmilewitz D., Karmeli F., Takabayashi K. et al. (2002) Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122, 1428-1441.
25. Randow F., Syrbe U., Meisel C. et al. (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 181, 1887-1892.
26. Ruas-Madiedo P., de los Reyes-Gavilán C.G. (2005) Invited review: methods for the screening, isolation, and characterization of exopolysaccharides produced by lactic acid bacteria. J. Dairy Sci. 88, 843-856.
27. Ruas-Madiedo P., Gueimonde M., Margolles A., de los Reyes-Gavilán C.G., Salminen S. (2006) Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. J. Food. Prot. 69, 2011-2015.
28. Sengül N., Aslím B., Uçar G. et al. (2006) Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats. Dis. Colon Rectum 49, 250-258.
29. Sengül N., Ioik S., Aslim B., Uçar G., Demirbaǧ A.E. (2011) The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis. Dig. Dis. Sci. 56, 707-714.
30. Servin A.L. & Coconnier M.H. (2003) Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract. Res. Clin. Gastroenterol. 17, 741-754.
31. Shida K. & Nanno M. (2008) Probiotics and immunology: separating the wheat from the chaff. Trends Immunol. 29, 565-573.
32. Shnyra A., Brewington R., Alipio A., Amura C., Morrison D.C. (1998) Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J. Immunol. 160, 3729-3736.
33. Szymański H., Armańska M., Kowalska-Duplaga K., Szajewska H. (2008) Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion 78, 13-17.
34. Vaarala O. (2003) Immunological effects of probiotics with special reference to lactobacilli. Clin. Exp. Allergy 33, 1634-1640.
35. Vidal K., Donnet-Hughes A., Granato D. (2002) Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect. Immun. 70, 2057-2064.
36. Vu B., Chen M., Crawford R.J., Ivanova E.P. (2009) Bacterial extracellular polysaccharides involved in biofilm formation. Molecules 14, 2535-2554.
37. Vuong C., Kocianova S., Voyich J.M. et al. (2004) A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 279, 54881-54886.
38. Watnick P., Kolter R. (2000) Biofilm, city of microbes. J. Bacteriol. 182, 2675-2679.
39. Zhang X. & Morrison D.C. (1993) Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukoc. Biol. 54, 444-450.
40. Zhang L., Li N., Caicedo R., Neu J. (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J. Nutr. 135, 1752-1756.
41. Zhang D., Chen L., Li S., Gu Z., Yan J. (2008) Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun. 14, 99-107.